Free Trial

Horizon Kinetics Medical ETF Rating

$27.72 +0.34 (+1.24%)
Closing price 08/1/2025 02:35 PM Eastern
Extended Trading
$27.72 +0.00 (+0.00%)
As of 08/1/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Horizon Kinetics Medical ETF Aggregate Rating and Price Target (2025)

MarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.

MEDX Aggregate Rating

Moderate Buy
2.65

Holdings in MEDX have an aggregate rating of Moderate Buy based on 363 analyst ratings issued in the past year covering 23 companies (84.4% of the portfolio).

MEDX Aggregate Price Target

$27.72
High Prediction$27.72
Average Prediction$27.72
Low Prediction$27.72

Holdings in MEDX have an aggregate price target of $27.72 and a range of $27.72 to $27.72 covering 23 companies (84.4% of the portfolio).

MEDX Consensus Ratings of Holdings

Strong Buy
1 Strong Buy rating(s)
Buy
2 Buy rating(s)
Moderate Buy
13 Moderate Buy rating(s)
Hold
7 Hold rating(s)
Reduce
0 Reduce rating(s)
Sell
0 Sell rating(s)
Strong Sell
0 Strong Sell rating(s)

Ratings for Stocks Held by Horizon Kinetics Medical ETF

 
 
Strong Sell
Sell
Reduce
Hold
Moderate Buy
Buy
Strong Buy

Ratings for the Top 23 MEDX Holdings

Weight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)View
Ratings
16.06%
Eli Lilly and Company stock logo
LLY
Eli Lilly and Company
$761.47
+2.9%
4.9115 of 5 stars
2.75$1,012.56 33.0%20Trending News
Upcoming Earnings
8.91%
AbbVie Inc. stock logo
ABBV
AbbVie
$195.17
+3.3%
4.5777 of 5 stars
2.81$212.81 9.0%27Trending News
Earnings Report
Analyst Forecast
Analyst Revision
6.09%
Amgen Inc. stock logo
AMGN
Amgen
$296.88
+0.6%
4.5229 of 5 stars
2.35$307.27 3.5%23News Coverage
Positive News
Upcoming Earnings
Dividend Announcement
5.77%
Alnylam Pharmaceuticals, Inc. stock logo
ALNY
Alnylam Pharmaceuticals
$401.80
+2.4%
3.8578 of 5 stars
2.81$392.13 -2.4%26Trending News
Analyst Forecast
5.37%
AstraZeneca PLC stock logo
AZN
AstraZeneca
$73.95
+1.2%
3.5117 of 5 stars
2.83$89.00 20.4%6Positive News
Earnings Report
Dividend Cut
5.11%
Bristol Myers Squibb Company stock logo
BMY
Bristol Myers Squibb
$44.25
+2.2%
4.8693 of 5 stars
2.38$57.33 29.6%21Trending News
Earnings Report
Analyst Forecast
Analyst Revision
4.81%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$167.33
+1.6%
4.6671 of 5 stars
2.65$174.50 4.3%20Trending News
Analyst Revision
4.16%
Alkermes plc stock logo
ALKS
Alkermes
$26.55
+0.2%
4.7519 of 5 stars
2.83$41.08 54.7%12News Coverage
Earnings Report
Analyst Forecast
Analyst Revision
4.05%
Pfizer Inc. stock logo
PFE
Pfizer
$23.49
+0.9%
4.952 of 5 stars
2.50$28.28 20.4%20Trending News
Upcoming Earnings
3.36%
Merck & Co., Inc. stock logo
MRK
Merck & Co., Inc.
$79.27
+1.5%
4.997 of 5 stars
2.35$107.44 35.5%20Trending News
Earnings Report
Analyst Forecast
Options Volume
Analyst Revision
3.34%
CRISPR Therapeutics AG stock logo
CRSP
CRISPR Therapeutics
$56.09
-0.3%
2.8208 of 5 stars
2.50$70.07 24.9%16News Coverage
Upcoming Earnings
Analyst Revision
3.22%
Ionis Pharmaceuticals, Inc. stock logo
IONS
Ionis Pharmaceuticals
$43.03
+0.1%
4.5482 of 5 stars
2.86$59.38 38.0%14Trending News
Earnings Report
Analyst Forecast
Insider Trade
2.66%
GSK PLC Sponsored ADR stock logo
GSK
GSK
$37.53
+1.0%
2.4948 of 5 stars
2.11$37.38 -0.4%9Trending News
Earnings Report
Dividend Cut
Analyst Upgrade
2.51%
Biogen Inc. stock logo
BIIB
Biogen
$131.95
+3.1%
4.8435 of 5 stars
2.34$185.63 40.7%32Trending News
Earnings Report
Analyst Forecast
Analyst Revision
High Trading Volume
2.40%
Regeneron Pharmaceuticals, Inc. stock logo
REGN
Regeneron Pharmaceuticals
$558.87
+2.5%
4.9314 of 5 stars
2.75$828.86 48.3%24Trending News
Analyst Forecast
Gap Up
1.14%
Beam Therapeutics Inc. stock logo
BEAM
Beam Therapeutics
$18.83
-4.5%
2.6192 of 5 stars
3.07$48.75 158.9%15News Coverage
Upcoming Earnings
Insider Trade
Gap Down
0.91%
Intellia Therapeutics, Inc. stock logo
NTLA
Intellia Therapeutics
$11.49
-1.3%
4.5829 of 5 stars
2.65$33.37 190.4%20News Coverage
Upcoming Earnings
Gap Down
0.88%
Haleon PLC Sponsored ADR stock logo
HLN
Haleon
$9.67
+2.5%
3.9158 of 5 stars
2.73$12.33 27.5%11News Coverage
Upcoming Earnings
Gap Up
0.86%
Replimune Group, Inc. stock logo
REPL
Replimune Group
$7.60
+8.1%
3.8822 of 5 stars
2.33$7.67 0.9%12Trending News
Analyst Upgrade
Options Volume
Gap Down
0.78%
Vanda Pharmaceuticals Inc. stock logo
VNDA
Vanda Pharmaceuticals
$4.19
-1.6%
4.3348 of 5 stars
3.50$16.50 293.8%2Trending News
Earnings Report
Analyst Downgrade
Short Interest ↑
0.71%
Galectin Therapeutics Inc. stock logo
GALT
Galectin Therapeutics
$3.65
+0.3%
2.5207 of 5 stars
3.00$6.00 64.4%1Positive News
0.65%
Sandoz Group AG Sponsored ADR stock logo
SDZNY
Sandoz Group
$56.99
0.0%
1.6244 of 5 stars
2.002Upcoming Earnings
0.64%
Bicycle Therapeutics PLC Sponsored ADR stock logo
BCYC
Bicycle Therapeutics
$7.99
-6.2%
3.5798 of 5 stars
2.70$24.22 203.2%10Positive News
Upcoming Earnings

This page (NASDAQ:MEDX) was last updated on 8/3/2025 by MarketBeat.com Staff
From Our Partners